| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/GCC.20420 |
| P698 | PubMed publication ID | 17243160 |
| P50 | author | Martin Dyer | Q53138021 |
| José I Martín-Subero | Q39062643 | ||
| P2093 | author name string | Reiner Siebert | |
| Peter Möller | |||
| Stefan Gesk | |||
| Marc A Weniger | |||
| Thomas F E Barth | |||
| Steve Ehrlich | |||
| P2860 | cites work | Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma. | Q53620559 |
| The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. | Q53931762 | ||
| Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma. | Q55042257 | ||
| Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma | Q56915483 | ||
| The BCL11AXL transcription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells | Q57447372 | ||
| Lack of IKBA coding region mutations in primary mediastinal large B-cell lymphoma and the host response subtype of diffuse large B-cell lymphoma | Q58051632 | ||
| The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma | Q73309612 | ||
| I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity | Q24318573 | ||
| Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma | Q24672476 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| The c-Rel transcription factor and B-cell proliferation: a deal with the devil | Q28241767 | ||
| Shaping the nuclear action of NF-kappaB | Q29614600 | ||
| Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation | Q33236181 | ||
| The BCL11 gene family: involvement of BCL11A in lymphoid malignancies | Q34102839 | ||
| Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. | Q34112913 | ||
| Development of a sensitive multi-well colorimetric assay for active NFkappaB | Q34233830 | ||
| Mediastinal (thymic) large B-cell lymphoma: where do we stand? | Q34688561 | ||
| Gene expression profiling of diffuse large B-cell lymphoma | Q35808389 | ||
| Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction | Q35848430 | ||
| Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2. | Q38486378 | ||
| Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells | Q39795545 | ||
| Genetic analysis of NF- B/Rel transcription factors defines functional specificities | Q39962410 | ||
| NF-kappaB-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity | Q40296221 | ||
| NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes | Q40427138 | ||
| Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line | Q40486172 | ||
| Stimulation of c-Rel transcriptional activity by PKA catalytic subunit beta | Q40545229 | ||
| Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma | Q40679662 | ||
| Genomic organization and expression of the rearranged REL proto-oncogene in the human B-cell lymphoma cell line RC-K8. | Q40741599 | ||
| PU.1/Spi-B regulation of c-rel is essential for mature B cell survival | Q40773247 | ||
| MedB-1, a human tumor cell line derived from a primary mediastinal large B-cell lymphoma | Q40814255 | ||
| Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line | Q40821711 | ||
| The precursor of NF-kappa B p50 has I kappa B-like functions | Q41598400 | ||
| Regulation of nuclear factor kappa B transactivation. Implication of phosphatidylinositol 3-kinase and protein kinase C zeta in c-Rel activation by tumor necrosis factor alpha | Q42502005 | ||
| Degradation of proto-oncoprotein c-Rel by the ubiquitin-proteasome pathway | Q42823633 | ||
| Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells | Q44611183 | ||
| Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas | Q47387310 | ||
| A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-kappaB and NFAT families | Q47393670 | ||
| RELevant gene amplification in B-cell lymphomas? | Q47800510 | ||
| P433 | issue | 4 | |
| P921 | main subject | B-cell lymphoma | Q4833719 |
| primary mediastinal B-cell lymphoma | Q53660452 | ||
| P304 | page(s) | 406-415 | |
| P577 | publication date | 2007-04-01 | |
| P1433 | published in | Genes, Chromosomes and Cancer | Q5532697 |
| P1476 | title | Gains of REL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein | |
| P478 | volume | 46 |
| Q36949574 | CAPERalpha is a novel Rel-TAD-interacting factor that inhibits lymphocyte transformation by the potent Rel/NF-kappaB oncoprotein v-Rel |
| Q34543027 | Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children |
| Q57279383 | Frequent occurrence of deletions in primary mediastinal B-cell lymphoma |
| Q40087598 | Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH). |
| Q35850206 | Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines |
| Q30873773 | High resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphoma |
| Q38651957 | High-depth, high-accuracy microsatellite genotyping enables precision lung cancer risk classification |
| Q38182355 | Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies |
| Q35909668 | Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling |
| Q38996724 | PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas |
| Q33889168 | Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies |
| Q37341168 | Peptidyl-prolyl isomerase Pin1 markedly enhances the oncogenic activity of the rel proteins in the nuclear factor-kappaB family |
| Q37905667 | Primary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies |
| Q34266819 | Primary mediastinal large B-cell lymphoma |
| Q37725413 | Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting |
| Q37327973 | Racial patterns of patients with primary mediastinal large B-cell lymphoma: SEER analysis |
| Q90041758 | Regulation of B-cell function by NF-kappaB c-Rel in health and disease |
| Q36495569 | Repression of B-cell linker (BLNK) and B-cell adaptor for phosphoinositide 3-kinase (BCAP) is important for lymphocyte transformation by rel proteins |
| Q52668197 | Ruxolitinib significantly enhances in vitro apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine model. |
| Q37781972 | The Basis and Rational Use of Molecular Genetic Testing in Mature B-cell Lymphomas |
| Q91658641 | The Unsolved Puzzle of c-Rel in B Cell Lymphoma |
| Q35556506 | The c-Rel Transcription Factor in Development and Disease |
| Q39135290 | XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy. |
| Q85896419 | [Lymph node pathology - an update] |
| Q26772234 | c-Rel and its many roles in cancer: an old story with new twists |
| Q90458228 | c-Rel gain in B cells drives germinal center reactions and autoantibody production |
Search more.